Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV) is the most common cause of respiratory tract infection in infants and children and shows increasing trend among elderly people worldwide. In many developing country settings, population and household structures have gone through some significant changes in the past...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Mahikul, W, White, L, Poovorawan, K, Soonthornworasiri, N, Sukontamarn, P, Chanthavilay, P, F Medley, G, Pan-Ngum, W
Formato:	Journal article
Idioma:	English
Publicado em:	Public Library of Science 2019

Registros relacionados

Modeling household dynamics on Respiratory Syncytial Virus (RSV).
por: Wiriya Mahikul, et al.
Publicado em: (2019-01-01)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis
por: Mahikul, W, et al.
Publicado em: (2019)

A population dynamic model to assess the diabetes screening and reporting programs and project the burden of undiagnosed diabetes in Thailand
por: Mahikul, W, et al.
Publicado em: (2019)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis.
por: Wiriya Mahikul, et al.
Publicado em: (2019-05-01)

Pathobiology of Respiratory Syncytial Virus (RSV)
por: Ralph A. Tripp, et al.
Publicado em: (2020-07-01)

Respiratory Syncytial Virus (RSV) Update
por: Leonard R. Krilov, et al.
Publicado em: (2022-09-01)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
por: Kinyanjui, T, et al.
Publicado em: (2020)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England and Wales and Finland: seasonality and cross-protection.
por: White, L, et al.
Publicado em: (2005)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
por: Jackelyn Murray, et al.
Publicado em: (2022-04-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection
por: White, L, et al.
Publicado em: (2005)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
por: Dvir Gatt, et al.
Publicado em: (2023-01-01)

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
por: Pan-Ngum, W, et al.
Publicado em: (2016)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
por: Timothy Kinyanjui, et al.
Publicado em: (2020-04-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
por: Gengxin Zhang, et al.
Publicado em: (2024-10-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
por: Shira Hirsh, et al.
Publicado em: (2014-01-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
por: Mohamad El Labban, et al.
Publicado em: (2024-06-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
por: Mark R. Ackermann, et al.
Publicado em: (2012-10-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
por: Samuel PC Brand, et al.
Publicado em: (2020-03-01)

Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
por: Rachel J Derscheid, et al.
Publicado em: (2013-01-01)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
por: Antepowicz, A, et al.
Publicado em: (2018)

Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication
por: Tatyana M. Khomenko, et al.
Publicado em: (2021-12-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
por: Selir M. Straliotto, et al.
Publicado em: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
por: Selir M. Straliotto, et al.
Publicado em: (1994-03-01)

Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
por: Envera Lekic, et al.
Publicado em: (2024-05-01)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
por: Andrea Gastaldi, et al.
Publicado em: (2021-12-01)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
por: Harrison C. Bergeron, et al.
Publicado em: (2023-04-01)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus
por: Sameer Joshi, et al.
Publicado em: (2018-05-01)

Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
por: Enders Martin, et al.
Publicado em: (2005-03-01)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
por: Anne M Hause, et al.
Publicado em: (2017-01-01)

Model-based estimates of transmission of respiratory syncytial virus within households
por: Ivy K. Kombe, et al.
Publicado em: (2019-06-01)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
por: Anne M Hause, et al.
Publicado em: (2017-01-01)

Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
por: Patricia T. Campbell, et al.
Publicado em: (2020-11-01)

New Inhibitors of Respiratory Syncytial Virus (RSV) Replication Based on Monoterpene-Substituted Arylcoumarins
por: Tatyana M. Khomenko, et al.
Publicado em: (2023-03-01)

Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
por: Drysdale, S, et al.
Publicado em: (2020)

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain
por: Sara Jimeno Ruiz, et al.
Publicado em: (2024-11-01)

Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review
por: Anahita Poshtiban, et al.
Publicado em: (2024-08-01)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
por: Xiao Li, et al.
Publicado em: (2024-01-01)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Asunci&oacute;n Mej&iacute;as, et al.
Publicado em: (2008-09-01)

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
por: O'Hagan S, et al.
Publicado em: (2023-09-01)

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.
por: H K Brand, et al.
Publicado em: (2015-01-01)